Real-world experience and analytics-based solutions to achieve your objectives

A set of unique services underpinned through expertise across hundreds of products and therapeutic areas, first-hand payer decision-maker experience on staff, and dedicated analytic firepower

OUR SERVICES

New Product Planning

Comprehensive Planning for Successful Product Launches

  • Conducting market research and competitive analysis to identify market needs, target audiences, and commercial opportunities.
  • Supporting early asset valuation to inform investment decisions and optimize product development strategy.
  • Providing strategic recommendations to optimize early product positioning, preliminary pricing, and messaging to differentiate from competitors and maximize market potential.
Commercialization Strategy

Elevating Launch Excellence with a Customized Go-to-Market Strategy

  • Development of a comprehensive go-to-market strategy that considers market dynamics, target customers, and competitive landscape
  • Creation of customized tactics and messaging to engage key stakeholders, including healthcare providers, payers, patients, and intermediaries
  • Providing support for commercial execution, such as launch planning and execution, market access and reimbursement strategy, indication expansion, loss of exclusivity, and ongoing performance tracking and optimization.
Cross-Stakeholder Commercial Analytics

Advanced Analytics to Optimize Cross-Stakeholder Engagement (Payer, Patient, & Provider)

  • Formulary and claims data-based analytics to understand access dynamics, formulate payer/provider engagement strategy, design patient affordability programs and optimize account level contracting tactics
  • Patient level analytics to gain a nuanced understanding of the patient journey and market opportunity; Predictive patient finding in rare disease and oncology
  • Provider level analytics to characterize and predict physician/practice prescribing behavior; Data-driven health system archetyping to inform organized customer group engagement strategy
Landscape Assessment

Understanding the Payer Landscape to Support Optimal Market Access

  • In-depth analysis of the global payer environment to identify the most relevant stakeholders, formularies, and reimbursement policies
  • Assessment of current market dynamics and trends, including emerging competitors and market disruptions
  • Strategic recommendations to optimize market access, including pricing and reimbursement strategies, communication tactics, and value proposition development
Access Strategy

Navigating Payer Complexities to Optimize Commercial Success

  • Analytic and strategic methodologies to help define actionable access objectives that support overall commercial success
  • Provision of scientific advice and strategic guidance to optimize HTA submissions, including early dialogues, to support favorable recommendations for product approval, reimbursement, and pricing
  • Development of customized coding and reimbursement strategies to maximize product adoption and minimize barriers to access across target markets
Pricing and Contracting Strategy

Optimizing Pricing and Contracting Strategies to Achieve Access & Forecast Objectives

  • Development of customized pricing and contracting strategies that balance market access with revenue optimization, taking into account payer, healthcare provider, patient, and GPO considerations
  • Evaluation of current pricing and contracting practices, including market analysis and benchmarking, to identify areas for improvement and optimization
  • Socialization of defendable pricing recommendations to cross-functional stakeholders, including sales, marketing, and legal teams, to align pricing and contracting strategies effectively and efficiently with overall brand and company goals.
Payer Value Proposition Strategy

Compelling Global Payer Value Propositions for Optimizing Market Access

  • Development of customized payer value propositions that addresses the unique needs and challenges of US and global payer audiences/archetypes
  • Alignment of the value proposition with clinical and economic evidence, including real-world data, to demonstrate product value and differentiate from competitors
  • Strategic communication of the value proposition to key payer stakeholders, including health technology assessment agencies, to optimize pricing, reimbursement, and access.
Specialty Distribution & Patient Support Services

Enhancing Patient Access and Adherence Through Specialized Distribution and Support Services

  • Conducting detailed assessments via quantitative and qualitative primary and secondary research of customers (e.g., providers & patients) to best inform support distribution & patient support service requirements for launch and post-launch evolution
  • Identification and management of specialty pharmacy and distribution partner selection to ensure efficient and effective channel models
  • Development of customized patient support programs, including financial assistance, education, and nurse support, to enhance patient adherence and outcomes
Medical Affairs & Integrated Evidence Solutions

Driving Evidence-Based Product Adoption Through Medical Affairs and Integrated Evidence Solutions

  • Development of a medical affairs strategy that aligns with commercial objectives, including KOL engagement, medical education, and scientific communications
  • Creation of integrated evidence solutions that incorporate real-world data and clinical evidence to support product adoption and differentiate from competitors
  • Strategic recommendations for the intersection of clinical development, HEOR strategies, RWE, and commercialization success
Payer Rationalized Clinical Trial Design

Designing Clinical Trials That Meet Payer Requirements and Optimize Market Access

  • Providing strategic guidance on the design of pivotal clinical trials and real world evidence (RWE) strategy that meet payer requirements, optimize market access, and support product value proposition.
  • Conducting payer research or leveraging our in-house team of over 20 former payers to identify evidence needs and requirements for reimbursement and coverage decisions, and incorporating this insight into the clinical trial design process.
  • Developing clinical trial protocols that align with payer requirements and facilitate evidence generation for market access and reimbursement.